Workplan

Lumiblast is a 4.5-year project that aims at establishing a novel method to combat brain tumours by providing proof-of-concept in extra-cellular systems, Glioblastoma Multiforme (GBM) cell cultures and animal models.

Lumiblast`s innovative concept is based on combining Photo Dynamic Therapy (PDT) with a novel chemiluminescent (or self-luminous) substance so that the need for an external light source, such as a lamp or a laser, will be eliminated. This will bypass today`s main shortcoming of clinical PDT, namely the limited depth of light penetration into tissue.Lumiblast`s vision is to advance and take this breakthrough technology to the clinic within five to six years after the end of the FET Open project.

This project has received funding from the European Union's Horizon 2020 framework programme for research and innovation under grant agreement No 712921.